Literature DB >> 16724182

Favorable effect on postgraduate clinical practice of a drug-interaction exercise for undergraduate students.

Shuichi Tsuruoka1, Atsuhiro Kawaguchi, Kazuhiro Harada, Akio Fujimura.   

Abstract

AIM: Undergraduate students in Jichi Medical School participated in a laboratory exercise investigating the furosemide-probenecid interaction at the end of their clinical pharmacology (CP) course. The aim of this study was to determine whether they learned to recognize drug interactions better than students who did not take such a course.
METHODS: We conducted a postal survey of physicians who had graduated from Jichi Medical School or from other medical schools without a CP course including the exercise. Questions were asked concerning: (1) the recognition of furosemide-probenecid and nine other drug interactions, and (2) the need to anticipate drug interactions and their adverse effects before writing prescriptions.
RESULTS: The degree of the recognition of all drug interactions, and the percentage of physicians who responded that knowledge of drug interactions and adverse effects were essential before writing prescriptions, were significantly greater in physicians who had taken an undergraduate CP course than in those who had not.
CONCLUSIONS: CP courses with specific laboratory exercises on drug interactions lead future physicians to recognize drug interactions and their adverse effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724182     DOI: 10.1007/s00228-006-0142-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  The need for improving information systems on drug interactions in Japan.

Authors:  K Harada; A Fujimura
Journal:  Arch Intern Med       Date:  2000-07-10

Review 2.  Comparison of problem-and lecture-based pharmacology teaching.

Authors:  Martin C Michel; Angela Bischoff; Karl H Jakobs
Journal:  Trends Pharmacol Sci       Date:  2002-04       Impact factor: 14.819

3.  Towards a core curriculum in clinical pharmacology for undergraduate medical students in Europe.

Authors:  Michael Orme; Jurgen Frolich; Bozidar Vrhovac
Journal:  Eur J Clin Pharmacol       Date:  2002-11-20       Impact factor: 2.953

4.  Clinical pharmacology: principles and practice of drug therapy in medical education.

Authors:  Brian Whiting; Nicholas H G Holford; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

5.  Pregraduate teaching clinical pharmacology in Germany.

Authors:  Dirk O Stichtenoth; Jürgen C Frölich
Journal:  Eur J Clin Pharmacol       Date:  2004-05-13       Impact factor: 2.953

6.  Effects of probenecid on furosemide kinetics and natriuresis in man.

Authors:  J Honari; A D Blair; R E Cutler
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

7.  Education in clinical pharmacology at the Rijeka School of Medicine, Croatia.

Authors:  V Vlahović Palcevski; D Vitezić; G Zupan; A Simonić
Journal:  Eur J Clin Pharmacol       Date:  1998 Nov-Dec       Impact factor: 2.953

8.  Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid.

Authors:  V Pichette; P du Souich
Journal:  J Am Soc Nephrol       Date:  1996-02       Impact factor: 10.121

9.  Using student feedback on examination questions to promote fairness, item validity, and learning.

Authors:  C M Smith
Journal:  J Clin Pharmacol       Date:  1997-05       Impact factor: 3.126

10.  Furosemide-probenecid interaction as a laboratory exercise for undergraduate education in clinical pharmacology.

Authors:  A Kawaguchi; K Sugimoto ; M Ohmori; S Tsuruoka; K Harada; Y Kitoh; E Kobayashi; A Fujimura
Journal:  Clin Pharmacol Ther       Date:  2001-04       Impact factor: 6.875

View more
  1 in total

1.  Healthcare professional students' knowledge of drug-drug interactions.

Authors:  Amanda R Harrington; Terri L Warholak; Lisa E Hines; Ann M Taylor; Duane Sherrill; Daniel C Malone
Journal:  Am J Pharm Educ       Date:  2011-12-15       Impact factor: 2.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.